Detection of PitNET Tissue During TSS Using Bevacizumab-800CW

Clinical trial NCT04212793 · COMPLETED

Trial details

NCT number: NCT04212793
Sponsor: University Medical Center Groningen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pituitary Tumor Pituitary Adenoma Pituitary Macroadenoma

Start date: 2020-10-28
Primary completion: 2022-10-24
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.